What Happened
Life Sciences Companies Face Growing Uncertainty
A new survey from AlixPartners found that supply chain disruption has become a top challenge for life sciences companies, with nearly 30% of respondents citing it as their primary pain point. The findings come as pharmaceutical manufacturers and medical device companies face growing uncertainty around tariffs, sourcing, and global trade. According to the report, policy shifts, competitive pressures, and supply chain disruptions are major contributors to sustained margin compression, weakening the sector’s historical pricing power, as reported by Logistics Management.